Patent and Trademark Expenses Sample Clauses

Patent and Trademark Expenses. 11.3.1 Amgen shall have the right to charge (i) up to the date of Regulatory Approval to Commercialise the first Antibody Product, as a Research and Development Cost; and (ii) thereafter, to the Product Contribution account as a Commercialisation Expense; all of Amgen’s external costs, expenses and fees (as documented by written invoices for legal and expert services and receipts for filing and maintenance fees paid) to have outside counsel prepare, file, prosecute and maintain and/or defend [*] Patent Rights, [*] Patent Rights, [*] Patent Rights, [*] Patent Rights and Product Trademarks in accordance with Article 11 during the Term.
Sample 1Sample 2
AutoNDA by SimpleDocs
Patent and Trademark Expenses. (a) From the Effective Date of this Agreement, prior to the first commercial sale of a Collaboration Product, all worldwide Patent and Trademark Expenses will be treated as Development Expenses.
Sample 1Sample 2
Patent and Trademark Expenses. (a) With respect to carrying out its responsibilities under Section 9.4, Amgen shall have the right to charge the Operating Profit or Loss account for all of Amgen's external costs, expenses and fees (as documented by written invoices for legal services and receipts for filing, maintenance and other fees paid) to have outside counsel prepare, file, ex parte prosecute and maintain and/or defend Amgen Patent Rights, Joint Patent Rights and, if applicable, Product Trademarks before all patent and trademark offices in the Territory during the Term. Amgen shall obtain advance written consent from Hyseq (such consent not to be unreasonably withheld) in the event any such ex parte expenses collectively exceed [***] in any given Calendar Year; provided however, that the costs, expenses and fees to defend such Patent Rights in any inter partes actions before any such patent offices (including, without limitation, interferences and oppositions) shall be excluded from such [***]. In the event Hyseq does not consent to reimburse Amgen for such costs, expenses or fees in excess of such [***] in a Calendar Year for any aspect related to preparing, filing, ex parte prosecuting, maintaining or defending any of the Amgen Patent Rights, Joint Patent Rights and Product Trademarks in the Territory during the Term, Amgen shall not be obligated to continue any of its activities or to incur any further costs or expenses related to such aspect.
Sample 1Sample 2
Patent and Trademark Expenses. InterMune shall reimburse Amgen's costs (as documented by written invoices for legal services and receipts for filing and maintenance fees paid) to [*] provided that Amgen shall obtain advance written consent from InterMune (such consent not to be unreasonably withheld) in the event any such expenses [*] In the event InterMune does not consent to reimburse Amgen for any aspect related to [*] Amgen shall not be obligated to continue any of its activities or to incur any further costs or expenses related to such aspect.
Sample 1
Patent and Trademark Expenses. Buyer and Seller agree that all costs associated with the assignment of the patents and trademarks from Seller to Buyer, including attorneys fees and filing fees, shall be borne by Buyer.
Sample 1

Related to Patent and Trademark Expenses

  • Patent and Trademark Disputes Notwithstanding Section 16.2, any dispute, controversy or claim relating to the inventorship, scope, validity, enforceability or infringement of any Patents or Marks Covering the manufacture, use, importation, offer for sale or sale of Products shall be submitted to a court of competent jurisdiction in the country in which such patent or trademark rights were granted or arose.

  • Patents and Trademarks The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or material for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). Neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of the Intellectual Property Rights used by the Company or any Subsidiary violates or infringes upon the rights of any Person. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

  • Copyrights, Patents and Trademarks (i) To the best of each Obligor’s knowledge, each Copyright, Patent and Trademark of such Obligor is valid, subsisting, unexpired, enforceable and has not been abandoned.

  • Copyrights, Patents, Trademarks and Licenses, etc The Company and each Subsidiary own or are licensed or otherwise have the right to use all of the material patents, trademarks, service marks, trade names, copyrights, contractual franchises, authorizations and other rights that are reasonably necessary for the operation of their respective businesses, without material conflict with the rights of any other Person. To the best knowledge of the Company, no slogan or other advertising device, product, process, method, substance, part or other material now employed, or now contemplated to be employed, by the Company or any Subsidiary infringes upon any rights held by any other Person. Except as specifically disclosed in Schedule 6.5, no claim or litigation regarding any of the foregoing is pending or, to the knowledge of the Company, threatened, and no patent, invention, device, application, principle or any statute, law, rule, regulation, standard or code is pending or, to the knowledge of the Company, proposed, which, in either case, would reasonably be expected to have a Material Adverse Effect.

  • Patents, Trademarks There are no material patents, patent rights, trademarks, service marks, trade names, copyrights, licenses or other intellectual property rights with respect to the Leased Property that are necessary for the operation of the Leased Property by the Lessee, except to the extent that the Lessee has rights in respect thereof without material payment of royalties or other material licensing payments, which rights may be freely leased, licensed or otherwise provided to Lessor or any successor owner, lessee, user or operator of the Leased Property pursuant to the Operative Documents.

  • Trademarks, Patents Borrower, as of the date hereof, possesses all necessary trademarks, trade names, copyrights, patents, patent rights, and licenses to conduct its business as now operated, without any known conflict with the valid trademarks, trade names, copyrights, patents and license rights of others.

  • Patents, Trademarks, Etc Each Borrower and their Subsidiaries owns, possesses, or has the right to use all necessary Patents, licenses, Trademarks, Copyrights, permits and franchises to own its properties and to conduct its business as now conducted, without known conflict with the rights of any other Person. Any and all obligations to pay royalties or other charges with respect to such properties and assets are properly reflected on the financial statements described in Section 4.1.11 (Financial Condition).

  • Trademark Use (a) Reseller acknowledges that the Vendor Trademarks are trademarks owned solely and exclusively by Vendor, and agrees to use the Vendor Trademarks only in the form and manner and with appropriate legends as prescribed by Vendor. Reseller agrees not to use any other trademark or service mark xx connection with any of the Vendor Trademarks without prior written approval of Vendor. All use of Vendor Trademarks shall inure to the benefit of Vendor.

  • Patents, Copyrights and Trademarks Schedule 5 lists all material Trademarks, material Copyrights and material Patents, in each case, registered in the United States Patent and Trademark Office or the United States Copyright Office, as applicable, and owned by such Grantor in its own name as of the date hereof, and all material Trademark Licenses, all material Copyright Licenses and all material Patent Licenses (including, without limitation, material Trademark Licenses for registered Trademarks, material Copyright Licenses for registered Copyrights and material Patent Licenses for registered Patents) owned by such Grantor in its own name as of the date hereof, in each case, that is solely United States Intellectual Property.

  • Trademarks and Trade Names (a) Each party hereby acknowledges that it does not have, and shall not acquire any interest in any of the other party’s trademarks or trade names unless otherwise expressly agreed.

Time is Money Join Law Insider Premium to draft better contracts faster.